MULE', Francesca Serena
 Distribuzione geografica
Continente #
AS - Asia 115
EU - Europa 103
NA - Nord America 102
SA - Sud America 11
AF - Africa 1
OC - Oceania 1
Totale 333
Nazione #
US - Stati Uniti d'America 100
SG - Singapore 73
GB - Regno Unito 39
CN - Cina 23
DE - Germania 14
HK - Hong Kong 14
FI - Finlandia 11
BR - Brasile 9
RU - Federazione Russa 9
FR - Francia 8
IE - Irlanda 7
SE - Svezia 7
IT - Italia 4
JP - Giappone 2
MX - Messico 2
PL - Polonia 2
PY - Paraguay 2
AT - Austria 1
AU - Australia 1
ID - Indonesia 1
KR - Corea 1
SC - Seychelles 1
UA - Ucraina 1
VN - Vietnam 1
Totale 333
Città #
Singapore 44
Southend 35
Woodbridge 20
Jacksonville 17
Hong Kong 14
Chandler 13
Houston 10
Dublin 7
Beijing 5
Munich 5
Dallas 4
Hebei 3
Helsinki 3
Lawrence 3
Princeton 3
Wilmington 3
Zhengzhou 3
Mexico City 2
Redwood City 2
Tokyo 2
Turku 2
Verona 2
Aracaju 1
Ashburn 1
Asunción 1
Belo Horizonte 1
Brooklyn 1
Cernusco sul Naviglio 1
Changsha 1
Charlotte 1
Chicago 1
Dom Pedro 1
Düsseldorf 1
Filadelfia 1
Frankfurt am Main 1
Ho Chi Minh City 1
Jakarta 1
London 1
Manaus 1
Muriaé 1
Nanjing 1
Norwalk 1
Novokuznetsk 1
Nuremberg 1
Pikeville 1
Rio de Janeiro 1
Shenyang 1
Sydney 1
São Bento do Sul 1
Taiyuan 1
Taizhou 1
Tianjin 1
Vienna 1
Volta Redonda 1
Warsaw 1
Wroclaw 1
Totale 236
Nome #
Commentary: Haloperidol, risperidone and olanzapine are similarly effective for first-episode non-affective psychosis but have differing side effects 141
Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia 114
Does the addiction of a second antipsychotic drug improve clozapine treatment? 80
Totale 335
Categoria #
all - tutte 1.180
article - articoli 1.180
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.360


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 1 3 2 0 2 2 0 0 0
2021/202218 1 6 0 3 0 0 0 0 0 0 4 4
2022/202344 3 5 6 4 7 8 0 2 7 0 0 2
2023/202422 2 2 2 2 0 1 0 1 0 0 6 6
2024/2025104 5 4 6 15 7 29 3 6 6 3 3 17
2025/202627 10 17 0 0 0 0 0 0 0 0 0 0
Totale 335